Ignite Creation Date:
2024-05-05 @ 11:59 AM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00202696
Status:
COMPLETED
Last Update Posted:
2008-05-19
First Post:
2005-09-12
Brief Title:
Nalmefene Smoking Cessation Study
Sponsor:
Somaxon Pharmaceuticals
Organization:
Somaxon Pharmaceuticals
Study Overview
Official Title:
A Single Center Evaluation of Nalmefene HCl Versus Placebo on Smoking Cessation
Status:
COMPLETED
Status Verified Date:
2008-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To determine if nalmefene is safe and effective in smoking cessation
Detailed Description:
Single centered randomized placebo-controlleddouble-blind outpatient pilot study to evaluate the efficacy safety and tolerability of 2 doses of nalmefene on smoking cessation
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None